Furthermore, 5-hydroxytryptamine receptor 3C (HTR3C), cerberus 1(CER1) and insulin-like 5(INSL5) were screened out for the 1st time and might have the potential to participate in the CAD process. Here, HTR3C is linked to coronary artery disorder.